Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EV/Core EBITDA

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 17.3929.7314.3411.4411.21

What is the latest EV/Core EBITDA ratio of INDOCO REMEDIES ?

The latest EV/Core EBITDA ratio of INDOCO REMEDIES is 17.39 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202617.39
Mar202529.73
Mar202414.34
Mar202311.44
Mar202211.21

How is EV/Core EBITDA of INDOCO REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2026 17.39
-41.51
Mar2025 29.73
107.32
Mar2024 14.34
25.35
Mar2023 11.44
2.05
Mar2022 11.21 -

Other Financial Ratios of INDOCO REMEDIES


Compare EV/Core EBITDA ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,318.6 Cr 3.6% 13.4% -5.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -1.6% -2.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr 1.5% 12.8% 48.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -0.9% -0.8% 35.3% Stock Analytics
CIPLA ₹112,773.0 Cr -1.6% -5.2% -11.7% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -2.2% -2.3% -8.2% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

3.6%

13.4%

-5.4%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses